Doyle Anthony 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed May 15, 2024
Insider Transaction Report
Form 4
Doyle Anthony
Chief Financial Officer
Transactions
- Purchase
Common Stock
2024-05-14$5.57/sh+36,300$202,191→ 266,744 total
4 · BIOCRYST PHARMACEUTICALS INC · Filed May 15, 2024
Common Stock